Start
•Completion
Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder
RecruitingRegisteredCTG
Proof-of-concept randomised clinical trial (n=30) of psilocybin-enhanced psychotherapy (two oral doses 25–30 mg) versus treatment-as-usual among veterans in residential treatment for methamphetamine use disorder.
Details
Randomised, parallel-group study in veterans admitted to residential rehabilitation comparing psilocybin-enhanced psychotherapy (4 preparatory visits, 2 dosing sessions, 8 integration visits) with treatment-as-usual.
Primary aims are acceptability, feasibility, and safety with primary endpoint at end of intervention; secondary aims assess preliminary efficacy for methamphetamine use disorder and overall functioning at 60- and 180-day follow-ups.
Topics:Substance Use Disorders (SUD)
Registry
Registry linkNCT04982796